Last updated: 2 March 2021 at 4:12pm EST

Anand Sampath Net Worth




The estimated Net Worth of Anand Sampath is at least $3.73 Million dollars as of 2 January 2021. Mr. Sampath owns over 2,000 units of Masimo Corp stock worth over $1,760,166 and over the last 15 years he sold MASI stock worth over $0. In addition, he makes $1,974,740 as Executive Vice President - Operations & Clinical Research at Masimo Corp.

Mr. Sampath MASI stock SEC Form 4 insiders trading

Anand has made over 15 trades of the Masimo Corp stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 2,000 units of MASI stock worth $223,060 on 2 January 2021.

The largest trade he's ever made was exercising 65,000 units of Masimo Corp stock on 31 October 2016 worth over $924,300. On average, Anand trades about 13,372 units every 65 days since 2009. As of 2 January 2021 he still owns at least 15,782 units of Masimo Corp stock.

You can see the complete history of Mr. Sampath stock trades at the bottom of the page.





Anand Sampath biography

Anand Sampath serves as Executive Vice President - Operations & Clinical Research of the Company. Prior to that, he served as Executive Vice President, Engineering since March 2007. He is an inventor on more than ten patents relating to patient monitoring, wireless networks and communications. From April 2006 to March 2007, Mr. Sampath was our Director of Systems Engineering. From October 1995 to March 2006, he held various positions, including Program Manager, Engineering Manager and Distinguished Member of Technical Staff, at Motorola, Inc. Mr. Sampath holds a B.S. in Engineering from Bangalore University.

What is the salary of Anand Sampath?

As the Executive Vice President - Operations & Clinical Research of Masimo Corp, the total compensation of Anand Sampath at Masimo Corp is $1,974,740. There are 4 executives at Masimo Corp getting paid more, with Joseph Kiani having the highest compensation of $14,996,100.



How old is Anand Sampath?

Anand Sampath is 53, he's been the Executive Vice President - Operations & Clinical Research of Masimo Corp since 2019. There are 15 older and 10 younger executives at Masimo Corp. The oldest executive at Masimo Corp is Thomas Harkin, 80, who is the Independent Director.

What's Anand Sampath's mailing address?

Anand's mailing address filed with the SEC is C/O MASIMO CORPORATION, 52 DISCOVERY, IRVINE, CA, 92618.

Insiders trading at Masimo Corp

Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill, and Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.



What does Masimo Corp do?

masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.



What does Masimo Corp's logo look like?

Masimo Corp logo

Complete history of Mr. Sampath stock trades at Masimo Corp

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
2 Jan 2021 Anand Sampath
EVP, Ops, and Clinical Research
Option 2,000 $268.38 $536,760
2 Jan 2021
15,782
15 Dec 2020 Anand Sampath
EVP, Ops, and Clinical Research
Option 30,000 $26.39 $791,700
15 Dec 2020
28,782
13 Apr 2020 Anand Sampath
EVP, Ops, and Clinical Research
Option 19,796 $21.77 $430,959
13 Apr 2020
33,578
2 Jan 2020 Anand Sampath
EVP, Ops, and Clinical Research
Option 2,000 $158.58 $317,160
2 Jan 2020
14,518
20 Nov 2019 Anand Sampath
EVP, Ops, and Clinical Research
Option 15,000 $31.01 $465,150
20 Nov 2019
27,518
14 Jun 2019 Anand Sampath
EVP, Ops, and Clinical Research
Option 30,000 $28.03 $840,900
14 Jun 2019
27,518
15 Jan 2019 Anand Sampath
EVP, Ops, and Clinical Research
Option 30,000 $21.97 $659,100
15 Jan 2019
42,518
2 Jan 2019 Anand Sampath
EVP, Ops, and Clinical Research
Option 2,000 $105.52 $211,040
2 Jan 2019
13,272
28 Nov 2018 Anand Sampath
EVP, Ops, and Clinical Research
Option 30,000 $20.19 $605,700
28 Nov 2018
41,272
27 Feb 2018 Anand Sampath
EVP, Ops, and Clinical Research
Option 2,000 $86.08 $172,160
27 Feb 2018
12,000
11 Jul 2017 Anand Sampath
EVP, Ops, and Clinical Research
Option 40,000 $28.72 $1,148,800
11 Jul 2017
40,000
12 Jan 2017 Anand Sampath
EVP, Ops, and Clinical Research
Option 10,000 $14.22 $142,200
12 Jan 2017
10,000
31 Oct 2016 Anand Sampath
EVP, Ops, and Clinical Research
Option 65,000 $14.22 $924,300
31 Oct 2016
13,655
31 Oct 2016 Anand Sampath
EVP, Ops, and Clinical Research
Option 65,000 $14.22 $924,300
31 Oct 2016
13,655
6 Nov 2015 Anand Sampath
EVP, Ops, and Clinical Research
Option 45,000 $11.11 $499,950
6 Nov 2015
15,000


Masimo Corp executives and stock owners

Masimo Corp executives and other stock owners filed with the SEC include: